| Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS. NRIZ study) on the clearance of mild COVID‐19 H Elalfy, T Besheer, A El‐Mesery, AH El‐Gilany, MAA Soliman, ... Journal of medical virology 93 (5), 3176-3183, 2021 | 69 | 2021 |
| Impact of toll-like receptors 2 (TLR2) and TLR 4 gene variations on HCV susceptibility, response to treatment and development of hepatocellular carcinoma in cirrhotic HCV patients M Neamatallah, M El-Bendary, H Elalfy, T Besheer, MA El-Maksoud, ... Immunological Investigations 49 (4), 462-476, 2020 | 43 | 2020 |
| Association of human leucocyte antigen Class I (HLA‐A and HLA‐B) with chronic hepatitis C virus infection in Egyptian patients YM Mosaad, RE Farag, MM Arafa, S Eletreby, HA El‐Alfy, BS Eldeek, ... Scandinavian journal of immunology 72 (6), 548-553, 2010 | 43 | 2010 |
| The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection M El-Bendary, M Neamatallah, H Elalfy, T Besheer, A Elkholi, M El-Diasty, ... British Journal of Biomedical Science 75 (4), 175-181, 2018 | 41 | 2018 |
| Prediction of fibrosis progression rate in patients with chronic hepatitis C genotype 4: role of cirrhosis risk score and host factors T Besheer, M El-Bendary, H Elalfy, M Abd El-Maksoud, M Salah, K Zalata, ... Journal of interferon & cytokine research 37 (3), 97-102, 2017 | 40 | 2017 |
| RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: A multicenter Egyptian study M El-Bendary, S Abd-Elsalam, T Elbaz, W El-Akel, A Cordie, T Elhadidy, ... Expert Review of Anti-infective Therapy 20 (2), 291-295, 2022 | 38 | 2022 |
| Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus T Besheer, H Elalfy, M Abd El-Maksoud, A Abd El-Razek, S Taman, ... World Journal of Gastroenterology 25 (11), 1366, 2019 | 34 | 2019 |
| Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients H Elalfy, W Elsherbiny, AA Rahman, D Elhammady, SW Shaltout, ... World journal of hepatology 8 (24), 1028, 2016 | 32 | 2016 |
| Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: role of ABCB11 genotype polymorphism and plasma bile acid levels T Besheer, M Arafa, M Abd El-Maksoud, H Elalfy, A Hasson, K Zalata, ... The Turkish Journal of Gastroenterology 29 (3), 299, 2018 | 23 | 2018 |
| Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4 T Besheer, A Razek, M El Bendary, M Abd El Maksoud, H Elalfy, K Zalata, ... Turk J Gastroenterol 28 (4), 283-288, 2017 | 23 | 2017 |
| Epidemiological aspects of intrafamilial spread of HCV infection in Egyptian population: a pilot study M El-Bendary, G Esmat, M Neamatallah, E Kamel, T Besheer, H Elalfy, ... Open Journal of Gastroenterology 4 (05), 228, 2014 | 23 | 2014 |
| Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma MA El-Maksoud, MR Habeeb, HF Ghazy, MM Nomir, H Elalfy, S Abed, ... European Journal of Gastroenterology & Hepatology 31 (6), 716-722, 2019 | 20 | 2019 |
| Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization H Elalfy, T Besheer, MA El-Maksoud, K Farid, M Elegezy, AM El Nakib, ... British Journal of Biomedical Science 75 (4), 187-191, 2018 | 20 | 2018 |
| Associations of human leucocyte antigen class II‐DQB 1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family‐based study M El‐Bendary, M Neamatallah, G Esmat, E Kamel, H Elalfy, T Besheer, ... Journal of viral hepatitis 23 (12), 961-970, 2016 | 20 | 2016 |
| Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular … K Farid, H Elalfy, SM Abo El-khair, H Elgamal, T Besheer, A Elmokadem, ... Expert Review of Gastroenterology & Hepatology 14 (12), 1203-1214, 2020 | 19 | 2020 |
| HLA class II-DRB1 alleles with hepatitis C virus infection outcome in Egypt: a multicentre family-based study M El-Bendary, M Neamatallah, H Elalfy, T Besheer, E Kamel, H Mousa, ... Annals of Hepatology 18 (1), 68-77, 2019 | 19 | 2019 |
| Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients RE Farag, MM Arafa, S El-Etreby, NS Saudy, BS Eldeek, HA El-Alfy, ... Archives of Iranian medicine 16 (2), 0-0, 2013 | 13 | 2013 |
| Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection M El-Bendary, M Neamatallah, H Elalfy, T Besheer, M El-Setouhy, ... British journal of biomedical science 76 (1), 11-16, 2019 | 12 | 2019 |
| A novel combination of C-reactive protein and vascular endothelial growth factor in differential diagnosis of ascites A Abdel-Razik, N Mousa, H Elalfy, TF Sheta, M Awad, M Abdelsalam, ... Journal of gastrointestinal cancer 48, 50-57, 2017 | 12 | 2017 |
| Caspase-cleaved cytokeratin 18 fragment M30 as a potential biomarker of macrovascular invasion in hepatocellular carcinoma H Elalfy, T Besheer, MM Arafa, MAB El-Hussiny, MA El Latif, SAM Alsayed Journal of Gastrointestinal Cancer 49, 260-267, 2018 | 11 | 2018 |
tarek besheerMANSOURA UNIVERSITY在 mans.edu.eg 的电子邮件经过验证
